XTL Biopharmaceuticals Ltd ADR (XTLB)

HEALTHCARE • BIOTECHNOLOGY • NASDAQ

$1.96

+0.08 (+4.26%)

Market Cap: $4.62M

Last updated: Oct 16, 2026 at 1:55 PM ET

Earnings

Period	Reported	Est.	Range	Surprise	B/M	Analysts	Revisions	YoY
Sep 30, 2025Sep 25 Reported Dec 29, 2025Reported Dec 29	$-0.01	$0.00	-	N/A	Miss	-	-	+92.3%
Mar 31, 2025Mar 25 Reported Apr 30, 2025Reported Apr 30	$0.00	$0.00	-	N/A	Beat	-	-	-100.0%
Dec 31, 2024Dec 24 Reported Jan 1, 2025Reported Jan 1	$-0.12	N/A	-	N/A	Beat	-	-	-123.8%
Sep 30, 2024Sep 24 Reported Dec 3, 2024Reported Dec 3	$-0.04	N/A	-	N/A	Beat	-	-	-11.6%
Jun 30, 2024Jun 24 Reported Sep 26, 2024Reported Sep 26	$-0.13	N/A	-	N/A	Beat	-	-	-93.4%
Mar 31, 2024Mar 24 Reported May 13, 2024Reported May 13	$0.09	N/A	-	N/A	Beat	-	-	+152.8%
Dec 31, 2023Dec 23 Reported Mar 27, 2024Reported Mar 27	$-0.05	$0.00	-	N/A	Miss	-	-	+62.1%
Sep 30, 2023Sep 23 Reported Nov 15, 2023Reported Nov 15	$-0.04	$0.00	-	N/A	Miss	-	-	+73.8%
Jun 30, 2023Jun 23 Reported Aug 10, 2023Reported Aug 10	$-0.07	$0.00	-	N/A	Miss	-	-	-27.7%
Mar 31, 2023Mar 23 Reported May 16, 2023Reported May 16	$-0.17	$0.00	-	N/A	Miss	-	-	-1397.7%
Dec 31, 2022Dec 22 Reported Mar 22, 2023Reported Mar 22	$-0.14	$0.00	-	N/A	Miss	-	-	-134.6%
Sep 30, 2022Sep 22 Reported Nov 29, 2022Reported Nov 29	$-0.15	$0.00	-	N/A	Miss	-	-	-0.1%
Jun 30, 2022Jun 22 Reported Aug 24, 2022Reported Aug 24	$-0.05	N/A	-	N/A	Beat	-	-	-3386.7%
Mar 31, 2022Mar 22 Reported Jun 1, 2022Reported Jun 1	$0.01	N/A	-	N/A	Beat	-	-	+690.9%
Dec 31, 2021Dec 21 Reported Mar 30, 2022Reported Mar 30	$0.40	N/A	-	N/A	Beat	-	-	+79160.0%
Sep 30, 2021Sep 21 Reported Nov 24, 2021Reported Nov 24	$-0.15	N/A	-	N/A	Beat	-	-	-3860.5%
Jun 30, 2021Jun 21 Reported Aug 24, 2021Reported Aug 24	$-0.00	N/A	-	N/A	Beat	-	-	-36.4%
Mar 31, 2021Mar 21 Reported May 19, 2021Reported May 19	$-0.00	N/A	-	N/A	Beat	-	-	-4.8%
Dec 31, 2020Dec 20 Reported Mar 15, 2021Reported Mar 15	$0.00	N/A	-	N/A	Beat	-	-	+400.0%
Sep 30, 2020Sep 20 Reported Dec 8, 2020Reported Dec 8	$-0.00	N/A	-	N/A	Beat	-	-	-280.0%
Jun 30, 2020Jun 20 Reported Aug 24, 2020Reported Aug 24	$-0.00	N/A	-	N/A	Beat	-	-	+89.0%
Mar 31, 2020Mar 20 Reported May 27, 2020Reported May 27	$-0.00	N/A	-	N/A	Beat	-	-	-121.0%
Dec 31, 2019Dec 19 Reported Mar 12, 2020Reported Mar 12	$0.00	N/A	-	N/A	Beat	-	-	-98.7%
Sep 30, 2019Sep 19 Reported Nov 27, 2019Reported Nov 27	$-0.00	N/A	-	N/A	Beat	-	-	-150.0%
Jun 30, 2019Jun 19 Reported Sep 4, 2019Reported Sep 4	$-0.01	N/A	-	N/A	Beat	-	-	-600.0%
Mar 31, 2019Mar 19 Reported May 30, 2019Reported May 30	$0.01	N/A	-	N/A	Beat	-	-	+9900.0%
Dec 31, 2018Dec 18 Reported Mar 11, 2019Reported Mar 11	$0.01	$0.00	-	N/A	Beat	-	-	+341.2%
Sep 30, 2018Sep 18 Reported Nov 1, 2018Reported Nov 1	$0.00	N/A	-	N/A	Beat	-	-	-99.4%
Jun 30, 2018Jun 18 Reported Jul 24, 2018Reported Jul 24	$0.00	N/A	-	N/A	Beat	-	-	-35.5%
Mar 31, 2018Mar 18 Reported May 29, 2018Reported May 29	$0.00	N/A	-	N/A	Beat	-	-	+103.7%
Dec 31, 2017Dec 17 Reported Mar 15, 2018Reported Mar 15	$0.00	$0.00	-	N/A	Beat	0	1 0 30d	+158.6%
Sep 30, 2017Sep 17 Reported Nov 27, 2017Reported Nov 27	$0.31	N/A	-	N/A	Beat	-	-	-
Jun 30, 2017Jun 17 Reported Sep 26, 2017Reported Sep 26	$0.00	N/A	-	N/A	Beat	-	-	-
Mar 31, 2017Mar 17 Reported Jun 15, 2017Reported Jun 15	$-0.00	N/A	-	N/A	Beat	-	-	-
Dec 31, 2016Dec 16 Reported Mar 30, 2017Reported Mar 30	$-0.00	N/A	-	N/A	Beat	0	No revisions (30d)	-

Key Metrics

Valuation
P/E Ratio	N/A	EV/EBITDA	N/A
Price/FCF	-2.10x	FCF Yield	-47.61%
Profitability
Profit Margin	0.00%	Operating Margin	0.00%
ROE	-29.30%	ROIC	N/A
Financial Health
Debt/Equity	-1.06x	Interest Coverage	N/A
Current Ratio	0.40x	Quick Ratio	0.40x
Trading Statistics
Beta	0.42	Avg Volume	8.29K
52-Week High	$5.64	52-Week Low	$1.86

Technical Indicators Dashboard

Moving Averages

SMA 10$2.00

SMA 20$2.14

SMA 50$2.44

SMA 200$2.76

EMA 10$2.01

EMA 20$2.13

EMA 50$2.35

EMA 200$2.87

MACD

Line: -0.15Signal: -0.14Hist: -0.01

ADX

ADX: 34.9+DI: 15.2-DI: 30.9

Aroon & PSAR

Aroon Up4.0

Aroon Down100.0

PSAR$2.22

Bollinger Bands

Upper Band$2.49

Lower Band$1.80

%B Position3214%(Upper)

Band Width0.23

RSI (14-Day)

Neutral

38.0

Momentum Oscillators

Stoch %K12.3

Stoch %D8.3

Williams %R-82.8

ROC (10d)-8.0%

Momentum-0.17

CCI (20d)-98.6

MFI (14d)19.1

Volatility Measures

ATR (14d)$0.14(7.3%)

StdDev (20d)0.17

Hist Vol73.3%(High)

Volume Flow

VWAP$1.94

OBV197.6M

AD Line130480421310.8B

CMF (20d)-0.529

Volume Metrics

Avg Vol (20d)8.9K

Vol Ratio0.8x

VWMA (20d)$2.09

Pivot Points

R3$1.97

R2$1.94

R1$1.91

Pivot Point$1.89

S1$1.85

S2$1.83

S3$1.80

Advanced Oscillators

TSI-26.99

Ultimate Osc36.3

KST-193.76

Financial Data

Quarter	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022
Total Revenue	$289,000	$289,000	$162,000	$0	$0	$0	$0	$0	$0	$-459,000	$0	$0
Cost of Revenue	$332,000	$332,000	$116,000	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	$-43,000	$-43,000	$162,000	N/A	N/A	N/A	N/A	N/A	N/A	$-459,000	N/A	N/A

Operating Expenses	$769,000	$1.10M	$926,000	$421,000	$175,000	$333	$151,000	$163,000	$251,000	$225,000	$204,000	$202,000
R&D	$32,000	$32,000	$54,000	$6,000	$6,000	$6	$6,000	$6,000	$13,000	$6,000	$3,000	$15,000
SG&A	$812,000	$706,000	$472,000	$415,000	$169,000	$194	$145,000	$157,000	$238,000	$219,000	$201,000	$187,000
Operating Income	$-812,000	$-812,000	$-764,000	$-421,000	$-175,000	$-200	$-151,000	$-163,000	$-251,000	$-225,000	$-204,000	$-202,000

Interest Income	$0	$2,000	$13,000	$9,000	$10,000	$11,000	$9,000	$9,000	$12,000	$16,000	$0	$5,000
Interest Expense	$36,000	$94,000	$93,000	$13,000	$16,000	$84	$28,000	$32,000	$25,000	$30,000	$10,000	$11,000
Income Before Tax	$-385,000	$-385,000	$-553,000	$-704,000	$485,000	$-284	$-215,000	$-364,000	$-919,000	$-748,000	$-821,000	$-285,000
Income Tax Expense	$-130,000	$0	$0	$0	$931,999	$0	$19,000	$23,000	$13,000	$-27,000	$-10,000	$6,000

Net Income	$-255,000	$-255,000	$-553,000	$-704,000	$485,000	$-284	$-215,000	$-364,000	$-919,000	$-748,000	$-821,000	$-285,000

EBITDA	$-429,250	$-479,000	$304,000	$-691,000	$659,999	$-199,750	$-186,750	$-331,750	$-893,749	$-224,750	$-895,750	$-273,750
EBIT	$-479,000	$-479,000	$-460,000	$-421,000	$484,999	$-200,000	$-187,000	$-332,000	$-894,000	$-225,000	$-896,000	$-274,000

* Some calculated fields are derived from available data when not provided by source

Related GNG Research

No research available

Be the first to write about XTLB

News

A three-year board term is proposed for Gilai Dolev at XTL Biopharmaceuticals (XTLB).

XTL Biopharmaceuticals Ltd. (XTLB) announced that Iris Shapira Yalon will resign from its board of directors, effective upon the appointment of her successor or by November 20...

Stock Titan•Oct 14, 2026 3:43 PM ET10/14/26•Neutral

Enterprise value to revenue forward of XTL Biopharmaceuticals Ltd. – TASE:XTLB

This article provides financial information for XTL Biopharmaceuticals Ltd. (TASE: XTLB), specifically focusing on its enterprise value to revenue forward. It indicates the stock's status as market closed with no trades...

TradingView•Aug 23, 2026 9:14 AM ET8/23/26•Neutral

XTL Biopharmaceuticals Ltd. Revenue Breakdown – TASE:XTLB

This page provides financial information for XTL Biopharmaceuticals Ltd. (TASE:XTLB) on the Tel Aviv Stock Exchange. It includes an overview of the company's financials, statistics, dividends, earnings...

TradingView•Aug 22, 2026 3:41 PM ET8/22/26•Neutral

XTLB Financials: Revenue Breakdown, Margins & Competitor Comparison

This article provides a financial overview of X T L Biopharmaceuticals Ltd (XTLB), detailing its revenue breakdown, profitability margins...

Intellectia AI•Aug 8, 2026 4:10 PM ET8/8/26•Somewhat-Bearish

[6-K] XTL BIOPHARMACEUTICALS LTD Current Report (Foreign Issuer)

XTL Biopharmaceuticals Ltd. (XTLB) has filed a Form 6-K reporting that a shareholder has initiated a motion for court authorization to file a derivative claim against the company's controlling shareholder and certain...

Stock Titan•Aug 5, 2026 7:11 PM ET8/5/26•Bearish

XTLB Valuation and Fair Value

P/FCF: -2.1x
PEG: 0.0x
P/B: -19.0x

See GNG's fair value

XTLB Profitability: Margins, ROIC and FCF

Operating margin: 0.0%
Net margin: 0.0%
ROE: -29.3%
FCF margin: -236.9%
FCF yield: -47.6%

XTLB Competitors

Company	Ticker
Intelligent Bio Solutions Inc.	INBS
Redhill Biopharma Ltd	RDHL
Gelteq Limited Ordinary Shares	GELS
bioAffinity Technologies, Inc.	BIAF
Xenetic Biosciences Inc	XBIO
Vivos Therapeutics Inc	VVOS
Cardio Diagnostics Holdings Inc	CDIO
Enlivex Therapeutics Ltd	ENLV

Sector: Healthcare

XTLB Bull Case vs Bear Case

Bear case

XTLB beat EPS estimates in 0.0% of its last 8 reported quarters.

XTLB Earnings: Beat Rate and Next Report

Beat rate: 0 of 8 quarters (0.0%)

Frequently Asked Questions About XTLB

Does XTLB pay dividends?

XTL Biopharmaceuticals Ltd ADR (XTLB) does not currently pay a regular dividend.

What is XTLB's market cap?

XTL Biopharmaceuticals Ltd ADR (XTLB) has a market capitalization of $4.62M with a current stock price of $1.96.

Get full access to GNG Research

Create a free account to access portfolio tracking, advanced tools, and more.

Create Free Account Log In